Early development of a celiac trunk aneurysm during anti-vascular endothelial growth factor receptor therapy

Surgery. 2014 Apr;155(4):729-30. doi: 10.1016/j.surg.2013.12.022. Epub 2013 Dec 27.

Authors

Armin Wiegering¹, Christian O Ritter², Bruno Allolio³, Andreas K Buck⁴, Christoph-Thomas Germer⁵, Udo Lorenz⁵

Affiliations

¹ Department of General-, Visceral-, Vascular- and Pediatric Surgery, University of Wuerzburg, Wuerzburg, Germany. Electronic address: Wiegering_a@ukw.de.
² Institute of Radiology, University of Wuerzburg, Wuerzburg, Germany.
³ Endocrinology and Diabetes Unit, Department of Internal Medicine I, University of Wuerzburg, Wuerzburg, Germany.
⁴ Department of Nuclear Medicine, University of Wuerzburg, Wuerzburg, Germany.
⁵ Department of General-, Visceral-, Vascular- and Pediatric Surgery, University of Wuerzburg, Wuerzburg, Germany.

PMID: 24612626
DOI: 10.1016/j.surg.2013.12.022

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Aneurysm / diagnosis*
Aneurysm / diagnostic imaging
Aneurysm / etiology
Celiac Artery* / diagnostic imaging
Enzyme Inhibitors / adverse effects
Enzyme Inhibitors / therapeutic use
Female
Humans
Quinazolines / adverse effects
Quinazolines / therapeutic use*
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*
Thyroid Neoplasms / drug therapy*
Thyroid Neoplasms / secondary
Tomography, X-Ray Computed
Treatment Outcome
Tyrphostins / adverse effects
Tyrphostins / therapeutic use*
Withholding Treatment

Substances

Enzyme Inhibitors
Quinazolines
Tyrphostins
RTKI cpd
Receptors, Vascular Endothelial Growth Factor